title: Reply to Di Paolo et al.
authors.affiliation: Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Policlinico Umberto I, Viale dell'Università.
authors.forename: Marco
authors.initials: M
authors.lastname: Falcone
authors.affiliation: Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Policlinico Umberto I, Viale dell'Università.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Russo
authors.affiliation: Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Policlinico Umberto I, Viale dell'Università.
authors.forename: Mario
authors.initials: M
authors.lastname: Venditti
authors.affiliation: Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Novelli
authors.affiliation: Albany College of Pharmacy and Health Sciences, New York.
authors.forename: Manjunath P
authors.initials: MP
authors.lastname: Pai
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology*; D017576:Daptomycin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin